Rules 4.7.3 and 4.10.3 ASX Listing Rules Appendix 4G (current at 29/09/2025) Page 1 Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations Name of entity RHYTHM BIOSCIENCES LIMITED ABN/ARBN Financial year ended: 59 619 459 335 30 June 2026 Our corporate...
FY26 Appendix 4G and Corporate Governance Statement
Filed with ASX ·
6ix hasn’t read this filing yet.
Rhythm Biosciences Limited on 6ix
Story so far
Earlier from Rhythm Biosciences
- FY26 Annual Report
- AGM date and closing date for director nominations
- Board Changes
- Initial ColoSTAT Assessment in UK opens new market access
- Initial Director's Interest Notice - Carl Stubbings
Later from Rhythm Biosciences
- Final Director's Interest Notice - Gavin Fox-Smith
- ColoSTAT Economic Study - Australian Public Health Savings
- Notice of Annual General Meeting/Proxy Form
- Quarterly Activities Report and Appendix 4C
- RHY Q1 FY27 Update
Follow Rhythm Biosciences into a list and get an email when it puts out news.
Follow Rhythm Biosciences